NCT03932396

Brief Summary

The objective of this study is to carry out a Micro-elimination program for HCV infection in a vulnerable population (people sentenced to non-custodial sentences). This group shares certain peculiarities with the prison population (vulnerability, addictions, mental disorders, etc.), is three times higher than the imprisoned population, and is regularly attended by Social Insertion Centers (CIS) in Spain. An additional objective is to link these people with the specific plans of the Government of Cantabria (Chronicity Plan, Care for Serious Mental Disorders, Harm Reduction Programs and the Center for Attention to Drug Addicts) as well as the Extended Bridge Program for Penitentiary Institutions, implementing the figure of a Navigator (a specialized professional in charge of helping subjects overcome barriers). It is an observational study based on the screening of disease in accordance with the recommendations of the health authorities. Once detected, patients will be referred to the corresponding specialized care following the usual clinical practice.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 30, 2019

Completed
10 days until next milestone

Study Start

First participant enrolled

May 10, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
Last Updated

April 30, 2019

Status Verified

April 1, 2019

Enrollment Period

1.8 years

First QC Date

April 23, 2019

Last Update Submit

April 29, 2019

Conditions

Keywords

hepatitis C virusnon-custodial sentencesaddictive behavioursMental diseaseNavigatorscreeningPOCT

Outcome Measures

Primary Outcomes (15)

  • Number of subjects screened for anti-HCV

    From march of 2019 to march of 2021

  • Percentage of anti-HCV positive

    From march of 2019 to march of 2021

  • Number of anti-HCV positive subjects with detectable viremia

    From march of 2019 to march of 2021

  • Percentage of subjects with detectable viremia

    From march of 2019 to march of 2021

  • To detect other comorbidities such as mental disorders, drug dependencies in this population and link these patients with specific health care programs of Penitentiary Institutions (Extended Bridge Program) and the Government of Cantabria (Chronicity and

    From march of 2019 to march of 2021

  • Number of subjects screened for mental illness.

    From march of 2019 to march of 2021

  • Percentage of subjects with mental illness

    From march of 2019 to march of 2021

  • Number of subjects screened for drug addiction

    From march of 2019 to march of 2021

  • Percentage of subjects with drug addiction

    From march of 2019 to march of 2021

  • Number of subjects linked to the Chronicity Program of the Government of Cantabria

    From march of 2019 to march of 2021

  • Percentage of subjects linked to the Chronicity Program of the Government of Cantabria

    From march of 2019 to march of 2021

  • Number of subjects linked to the Extended Bridge program of Penitentiary Institutions

    From march of 2019 to march of 2021

  • Percentage of subjects linked to the Extended Bridge program of Penitentiary Institutions

    From march of 2019 to march of 2021

  • Number of subjects served by the Navigator

    From march of 2019 to march of 2021

  • Number of subjects with an average rating greater than 4 on a Likert scale of 5 points of satisfaction with the Navigator

    From march of 2019 to march of 2021

Study Arms (1)

Single group of subjects who fulfill the inclusion criteria

All the population condemned to a non-custodial sentence that is presented in the Service of Management of Penalties and Alternative Measures of the Center of Social Insertion (CIS) José Hierro CP Dueso during the study period (March 2019 and March 2021) , with ages between 18 and 79 years (approximately 1000 people / year) and willing to participate (signs the IC).

Other: Observational study

Interventions

No intervention is planned outside of usual clinical practice. Only active screening for hepatotropic virus infection, mainly hepatitis C virus, HIV, and mental illness will be carried out. If any disease is detected, patients will be referred to the corresponding specialized care following the usual clinical practice.

Single group of subjects who fulfill the inclusion criteria

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All the population condemned to a non-custodial sentence that is presented in the Service of Management of Penalties and Alternative Measures of the Center of Social Insertion (SIC) José Hierro CP Dueso during the study period (March 2019 and March 2021) , with ages between 18 and 79 years (approximately 1000 people / year) and willing to participate (signs the IC).

You may qualify if:

  • the entire population served in the Management of Penalties and Alternative Measures Service (SGPMA) of the José Hierro SIC, including new admissions within the study period.

You may not qualify if:

  • they are not willing to participate and do not sign informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Marqués de Valdecilla

Santander, Cantabria, 39008, Spain

Location

Related Publications (2)

  • Cuadrado A, Llerena S, Cobo C, Pallas JR, Mateo M, Cabezas J, Fortea JI, Alvarez S, Pellon R, Crespo J, Echevarria S, Ayesa R, Setien E, Lopez-Hoyos M, Crespo-Facorro B, Aguero J, Chueca N, Garcia F, Calleja JL, Crespo J. Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm. Am J Gastroenterol. 2018 Nov;113(11):1639-1648. doi: 10.1038/s41395-018-0157-x. Epub 2018 Jun 27.

    PMID: 29946175BACKGROUND
  • Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013 Mar;58(3):593-608. doi: 10.1016/j.jhep.2012.12.005.

MeSH Terms

Conditions

Mental DisordersHepatitis C

Interventions

Observation

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsHepatitis, Viral, HumanVirus DiseasesFlaviviridae InfectionsRNA Virus InfectionsHepatitisLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Central Study Contacts

Antonio Cuadrado Lavín, MD

CONTACT

Lucía Lavín Alconero, Bsc,PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2019

First Posted

April 30, 2019

Study Start

May 10, 2019

Primary Completion

March 1, 2021

Study Completion

March 31, 2021

Last Updated

April 30, 2019

Record last verified: 2019-04

Locations